Emergent BioSolutions (EBS) Goodwill & Intangibles (2010 - 2026)

Emergent BioSolutions' Goodwill & Intangibles history runs 17 years deep, the most recent figure standing at $470.4 million for Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 3.05% year-over-year to $470.4 million; the TTM figure through Mar 2026 stood at $470.4 million (down 3.05% YoY), while the FY2025 annual figure was $436.5 million, down 12.96% from the prior year.
• Goodwill & Intangibles was $470.4 million for Q1 2026 at Emergent BioSolutions, up from $436.5 million in the prior quarter.
• In the past five years, Goodwill & Intangibles ranged from a high of $949.8 million in Q3 2022 to a low of $436.5 million in Q4 2025.
• Historically, Goodwill & Intangibles has averaged $630.5 million across 5 years, with a median of $550.4 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles advanced 14.17% in 2022, then plunged 40.17% in 2023.
• A 5-year view of Goodwill & Intangibles shows it stood at $947.0 million in 2022, then slumped by 40.17% to $566.6 million in 2023, then declined by 11.49% to $501.5 million in 2024, then fell by 12.96% to $436.5 million in 2025, then increased by 7.77% to $470.4 million in 2026.
• The last three Goodwill & Intangibles figures came in at $470.4 million (Q1 2026), $436.5 million (Q4 2025), and $452.7 million (Q3 2025), per Business Quant data.